RESEARCH TRIANGLE PARK, NC – The Burroughs Wellcome Fund’s Board of Directors is pleased to announce the 2022 award recipients for the Career Awards for Medical Scientist program. BWF’s investment of 9.8 million dollars to this year’s cohort represents its largest commitment to date.
The Career Awards for Medical Scientists is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service.
“The talent in this year’s applicant pool was exceptional,” said Dr. Paige Cooper, BWF Program Officer. “BWF continues to be committed to investing in the careers of physician-scientists and we look forward to supporting their clinical research impact.”
The 2022 Career Awards for Medical Scientists recipients are:
Alice Cheng, MD, PhD
Stanford University
Engineering a synthetic microbial community for research and treatment of Nonalcoholic steatohepatitis
Theodore George Drivas, MD, PhD
University of Pennsylvania
Discovering molecular and genetic mechanisms of ciliary signaling in common disease
William Allen Freed-Pastor, MD, PhD
Harvard Medical School
Overcoming T cell exclusion to augment immunotherapy in pancreatic cancer
Alexander Gitlin, MD, PhD
Stanford University
Insights from complex immune disorders: how an apoptotic caspase unleashes inflammation
Gil Hoftman, MD, PhD
University of California-Los Angeles
Imaging transcriptomics across developmental stages of early psychotic illness
William L Hwang, MD, PhD
Harvard Medical School
Identifying key regulators of the neuronal-like malignant phenotype and tumornerve crosstalk in pancreatic cancer
Maya Evelyn Kotas, MD, PhD
University of California-San Francisco
Understanding the role of tuft cells in allergic airway disease
Juan Carlos Osorio, MD
Memorial Sloan-Kettering Cancer Center
Optimization of Fc Effector Activity of Anti-CD47 Antibodies for Cancer Immunotherapy
Kartik Pattabiraman, MD, PhD
Yale University
Developmental disruption of prefrontal circuits as the neurodevelopmental etiology of schizophrenia
Jessica Renee Queen, MD, PhD
Johns Hopkins University School of Medicine
A Microbiota-Induced Switch to Immune Checkpoint Inhibitor Responsiveness in Colon Cancer
Carolyn Sangokoya, MD, PhD
University of California-San Francisco
Illuminating post-transcriptional control of stem cell fate and function
Jay Sarthy, MD, PhD
Fred Hutchinson Cancer Research Center
Interrogation of Pathological Histone Dynamics to Identify Drivers of Tumor Heterogeneity and Therapeutic Vulnerabilities
Christina Theodoris, MD, PhD
Harvard Medical School
Transfer learning leveraging large-scale single cell transcriptomics to enable predictions in settings with limited data
Josephine Wanjiru Thinwa, MD, PhD
University of Texas Southwestern Medical Center-Dallas
The Function of CDKL5 in autophagy and host antiviral defense
Comments are closed.